Intra-Cellular Therapies Inc (ICTI) is a biopharmaceutical company that discovers and develops and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders. The company pipeline includes lumateperone for the treatment of major depressive disorder and bipolar depression and TI-1284-ODT-SL for the treatment of agitation and psychosis in patients with Alzheimer’s. ICTI's other pipeline includes PDE inhibitor for Parkinson’s and cancer immunotherapy and ITI-333 for opioid use disorder, pain and mood disorders. It also utilizes CNSProfile, a technology platform that monitors the phosphoprotein changes elicited by major psychotropic drug classes and subclasses and generates a unique molecular signature for drug compounds. ICTI is headquartered in New York, the US.
Headquarters
United States of America
Address
430 East 29th Street, Suite 900, New York, 10016
Website
www.intracellulartherapies.com
Telephone
1 646 4409333
No of Employees
610
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
ITCI (NASD)
Revenue (2022)
$464.4M
85.5%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
45.5%
(2022 vs 2021)
Market Cap*
$6.4B
Net Profit Margin (2022)
XYZ
70.6%
(2022 vs 2021)
* As of and is in US$
Intra-Cellular Therapies Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pipeline | CNSProfile |
| Lumateperone - major depressive disorder, MDD and Bipolar Depression | CAPLYTA |
| TI-1284-ODT-SL - Alzheimer’s (Agitation, Psychosis) and Generalized Anxiety Disorder | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | Intra-Cellular Therapies Inc | Supernus Pharmaceuticals Inc | Axsome Therapeutics Inc | Concert Pharmaceuticals Inc | Intellect Neurosciences Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | New York | Rockville | New York | Lexington | Englewood Cliffs |
| State/Province | New York | Maryland | New York | Massachusetts | New Jersey |
| No. of Employees | 610 | 652 | 545 | - | - |
| Entity Type | Public | Public | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Sharon Mates Ph.D | Chief Executive Officer; President; Chairman | Executive Board | 2002 | 70 |
| Lawrence J. Hineline | Assistant Secretary; Chief Financial Officer; Senior Vice President - Finance; Treasurer | Senior Management | 2013 | 66 |
| Karen Sheehy | Senior Vice President; Chief Compliance Officer | Senior Management | - | - |
| Suresh Durgam | Chief Medical Officer; Executive Vice President | Senior Management | 2020 | 54 |
| Michael Halstead | President | Senior Management | 2024 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward